Spectrum Planning & Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Hold |
3,359
| – | – | 0.71% | 34 |
|
|
2025
Q1 | $907K | Hold |
3,359
| – | – | 0.76% | 28 |
|
|
2024
Q4 | $790K | Hold |
3,359
| – | – | 0.69% | 26 |
|
|
2024
Q3 | $924K | Sell |
3,359
-201
| -6% | -$55.3K | 0.89% | 21 |
|
|
2024
Q2 | $879K | Buy |
+3,560
| New | +$879K | 0.85% | 22 |
|
|
2023
Q4 | $681K | Hold |
3,560
| – | – | 0.97% | 24 |
|
|
2023
Q3 | $630K | Sell |
3,560
-31
| -0.9% | -$5.49K | 0.99% | 22 |
|
|
2023
Q2 | $681K | Hold |
3,591
| – | – | 1.02% | 20 |
|
|
2023
Q1 | $719K | Hold |
3,591
| – | – | 1.17% | 18 |
|
|
2022
Q4 | $853K | Sell |
3,591
-44
| -1% | -$10.5K | 1.16% | 22 |
|
|
2022
Q3 | $728K | Hold |
3,635
| – | – | 0.74% | 25 |
|
|
2022
Q2 | $530K | Hold |
3,635
| – | – | 0.55% | 30 |
|
|
2022
Q1 | $594K | Hold |
3,635
| – | – | 0.54% | 30 |
|
|
2021
Q4 | $616K | Hold |
3,635
| – | – | 0.56% | 31 |
|
|
2021
Q3 | $686K | Hold |
3,635
| – | – | 0.67% | 29 |
|
|
2021
Q2 | $616K | Hold |
3,635
| – | – | 0.59% | 31 |
|
|
2021
Q1 | $513K | Hold |
3,635
| – | – | 0.53% | 31 |
|
|
2020
Q4 | $472K | Buy |
+3,635
| New | +$472K | 0.51% | 31 |
|